US EditionPublished • loading... • Updated
After Obtaining Approval for Its Weight Loss Pill, Is It Off to the Races for Eli Lilly Stock?
Summary by The Motley Fool
1 Articles
1 Articles
After Obtaining Approval for Its Weight Loss Pill, Is It Off to the Races for Eli Lilly Stock?
Key PointsA weight loss pill would help Eli Lilly reach a broader segment of the population.Its existing GLP-1 drugs have already been generating billions in revenue growth for the business.The stock's high earnings multiple may be deterring some investors today.10 stocks we like better than Eli Lilly › On April 1, Eli Lilly (NYSE: LLY) and its shareholders received the news they were eagerly awaiting: the approval of the company's GLP-1 pill, F…
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
